Browse > Article
http://dx.doi.org/10.14776/piv.2021.28.e19

Severe Anemia Caused by Parvovirus B19 Infection in Two Pediatric Kidney Transplantation Recipients  

Kim, Kyung-Ran (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Hwanhee (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Doo Ri (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Cho, Heeyeon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Sanghoon (Division of Pediatric Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Suk-Koo (Division of Pediatric Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.28, no.3, 2021 , pp. 181-188 More about this Journal
Abstract
Anemia commonly occurs in kidney transplantation (KT) recipients. Many factors such as viral infection, bleeding, erythropoietin deficiency, and immunosuppressants are the causes of chronic anemia in KT recipients. We report 2 cases who developed severe anemia caused by parvovirus B19 infection and were successfully treated with intravenous immunoglobulin in pediatric KT recipients.
Keywords
Parvovirus B19; Kidney transplantation; Immunocompromised host; Anemia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Malbora B, Saritas S, Ataseven E, Belen B, Alparslan C, Yavascan O, et al. Pure red cell aplasia due to parvovirus B19: erythropoietin-resistant anemia in a pediatric kidney recipient. Exp Clin Transplant 2017;15:369-71.
2 Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Pediatr Transplant 2005;9:801-4.   DOI
3 Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006;43:40-8.   DOI
4 Winkelmayer WC, Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol 2008;3 Suppl 2:S49-55.   DOI
5 Winkelmayer WC, Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol 2008;3 Suppl 2:S49-55.   DOI
6 Mathias RS. Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient. Pediatr Nephrol 1997;11:355-7.   DOI
7 Eid AJ, Ardura MI; AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 2019;33:e13535.
8 Parvovirus B19 (erythema infectiosum, fifth disease). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, editors. Red book: 2021-2024 report of the Committee on Infectious Diseases. 32nd ed. Elk Grove Village, IL: American Academy of Pediatrics, 2021:562-566.
9 Pinto V, Grandy J, Zambrano P, Corta B, Salas P, Salgado I, et al. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports. Transplant Proc 2008;40:3261-4.   DOI
10 Shen Q, Xu H, Cao Q, Zhou LJ, Xu J, Fang XY, et al. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient. Pediatr Transplant 2011;15:E76-9.   DOI
11 Waldman M, Kopp JB. Parvovirus-B19-associated complications in renal transplant recipients. Nat Clin Pract Nephrol 2007;3:540-50.   DOI
12 Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 2004;15:1347-52.   DOI
13 Renoult E, Bachelet C, Krier-Coudert MJ, Diarrassouba A, Andre JL, Kessler M. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. Transplant Proc 2006;38:2321-3.   DOI
14 Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis 2013;56:968-77.   DOI
15 Barzon L, Murer L, Pacenti M, Biasolo MA, Vella MD, Ghirardo G, et al. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients. J Infect Dis 2009;200:1425-33.   DOI
16 Koo SE, Lee JH, Hahn H, Han DJ, Park YS. Parvovirus B19 infection in two Korean pediatric kidney transplant patients. J Korean Soc Pediatr Nephrol 2005;9:275-81.
17 Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC. Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant 2002;2:425-8.   DOI